What are the killer weapons of Lianying, Neusoft, and Mingfeng in the domestic CT internal competition?

On June 29th, according to information on the website of the Shanghai Stock Exchange, the review status of Mingfeng Medical, a company to be listed on the Science and Technology Innovation Board, has been changed to "accepted". This domestic CT top three enterprise has experienced the "biggest change" after 11 years of establishment.

According to the prospectus (application draft) of Mingfeng Medical, the planned shares to be issued this time will not exceed 150 million shares, not less than 10% of the total share capital after the issuance, and not more than 18.58% of the total share capital after the issuance. This issuance is all new shares, and no shareholders will be arranged to publicly issue shares. Haitong Securities Co., Ltd. is its recommendation institution.

The raised funds will be used for the project and the proposed fundraising amount is: the industrialization project of high-end medical imaging equipment, with a raised capital investment of approximately 265 million yuan; The R&D center construction project has raised approximately 159 million yuan of funds for investment; Supplement working capital and raise funds to invest 200 million yuan. After this stock issuance, it is planned to be listed on the Science and Technology Innovation Board of the Shanghai Stock Exchange.

(Source: Mingfeng Medical Prospectus)

Mingfeng Medical was established in 2011 and is a high-tech enterprise engaged in the research and development, production, sales, and technical services of medical imaging equipment. As one of the few medical device enterprises in China that can produce high-end CT and PET/CT, and also one of the few domestic enterprises that have successfully developed 256 row ultra high-end CT, we are expanding to other medical imaging equipment such as MRI, US, DR, etc.
 

The CT product line mainly includes 8 rows, 16 rows, 24 rows, 48 rows, 64 rows, 256 rows, in car CT series, Ark CT series, etc., covering clinical practical popularization models to ultra high-end scientific research models and mobile medical equipment. At the same time, it is also one of the few enterprises in China that engaged in the research and development of PET/CT products and obtained the registration license for medical devices.

 
According to the prospectus, the revenue share of high-end CT products of Mingfeng Medical has been on the rise for three consecutive years.